Identification of mimicry peptides based on sequential motifs of epitopes derived from 65-kDa glutamic acid decarboxylase

European Journal of Immunology

Volumn 28, Issue 6, 1998, Pages 1902-1910

  Bach, Jean Marie ^a   Otto, Heike ^b   Jung, Günther ^b   Cohen, Hélène ^a   Boitard, Christian ^a   Bach, Jean François ^a   Van Endert, Peter M ^a  

^a INSERM   (France)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Autoimmunity; Diabetes; Human; T lymphocyte

Indexed keywords

AUTOANTIGEN; EPITOPE; GLUTAMATE DECARBOXYLASE; HLA ANTIGEN CLASS 2;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CASE REPORT; CONTROLLED STUDY; DATA BASE; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE CLONE; LYMPHOID CELL LINE; PRIORITY JOURNAL; PROTEIN ANALYSIS; SEQUENCE HOMOLOGY; T LYMPHOCYTE ACTIVATION;

ADULT; ANTIBODIES; CELL LINE; DIABETES MELLITUS, TYPE 1; EPITOPE MAPPING; EPITOPES, T-LYMPHOCYTE; GLUTAMATE DECARBOXYLASE; HUMANS; MIDDLE AGED; PEPTIDES;

EID: 0031867791     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199806)28:06<1902::AID-IMMU1902>3.0.CO;2-J     Document Type: Article

References (32)

1. Wucherpfennig, K. W. and Strominger, J. L., Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 1995. 80: 695-705.
2. Oldstone, M. B. A., Molecular mimicry and autoimmune disease. Cell 1987. 50: 819-820.
3. Baum, H., Butler, P., Davies, H., Sternberg, M. J. E. and Burroughs, A. K., Autoimmune disease and molecular mimicry: a hypothesis. Trends Bioch. Sci. 1993. 18: 140-144.
4. Garza, K. M. and Tung, K. S., Frequency of molecular mimicry among T cell peptides as the basis for autoimmune disease and autoantibody induction. J. Immunol. 1995. 155: 5444-5448.
5. + T cells in the destruction of islet grafts by spontaneously diabetic mice. Proc. Natl. Acad. Sci. USA 1991. 88: 527-531.
6. Christianson, S. W., Shultz, L. D. and Leiter, E. H., Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Diabetes 1993. 42: 44-55.
7. Shizuru, J. A., Taylor-Edwards, S., Banks, A., Gregory, K. and Fathman, G., Treatment with an antibody to T helper lymphocytes. Science 1988. 240: 659-662.
8. Katz, J., D., Wang, B., Haskins, K., Benoist, C. and Mathis, D., Following a diabetogenic T cell from genesis through pathogenesis. Cell 1993. 74: 1089-1100.
9. Solimena, M. and De Camilli, P., Coxsackievirus and diabetes. Nature Med. 1995. 1: 25-27.
10. Jones, D. B. and Crosby, I., Proliferative lymphocyte responses to virus antigens homologous to GAD65 in IDDM. Diabetologia 1996. 39: 1318-1324.
11. Signore, A., Procaccini, E., Chianelli, M. and Pozzilli, P., Retroviruses and diabetes in animal models: hypotheses for the induction of the disease. Diab. Metabol. 1995. 21: 147-155.
12. Miyazaki, I., Cheung, R. K., Gaedigk, R., Hui, M. F., Van der Meulen, J., Rajotte, R. V. and Dosch, H.-M., T cell activation and anergy to islet cell antigen in type I diabetes. J. Immunol. 1995. 154: 1461-1469.
13. Evavold, B. D., Sloan-Lancaster, J., Wilson, K. J., Rothbard, J. B. and Allen, P. M., Specific T cell recognition of minimally homologous peptides: evidence for multiple endogenous ligands. Immunity 1995. 2: 655-663.
14. Ellis, T. M. and Atkinson, M. A., The clinical significance of an autoimmune response against glutamic acid decarboxylase. Nature Med. 1996. 2: 148-153.
15. Bach, J.-M., Otto, H., Nepom, G. T., Jung, G., Cohen, H., Timsit, J., Boitard, C. and Van Endert, P. M., High affinity presentation of an autoantigenic peptide in type I diabetes by an HLA class II protein encoded in a haplo-type protecting from disease. J. Autoimmun. 1997. 10: 375-386.
16. Thomson, G., Robinson, W. P., Kuhner, M. K., Joe, S., MacDonald, M. J., Gottschall, J. L., Barbosa, J., Rich, S. S., Bertrams, J., Baur, M. P., Partanen, J., Tait, B. D., Schober, E., Mayr, W. R., Ludvigsson, J., Lindblom, B., Farid, N. R., Thompson, C. and Deschamps, I., Genetic heterogeneity, modes of inheritance, and risk estimate for a joint study of Caucasians with insulin-dependent diabetes mellitus. Am. J. Hum. Genet. 1988. 43: 799-816.
17. Fleckenstein, B., Kalbacher, H., Muller, C. P., Stoll, D., Halder, T., Jung, G. and Wiesmuller, K. H., New ligands binding to the human leukocyte antigen class II molecule DRB1*0101 based on the activity pattern of an undecapeptide library. Eur. J. Biochem. 1996. 240: 71-77.
18. Rammensee, H. G., Friede, T. and Stefanoviç, S., MHC ligands and peptide binding motifs: first listing. Immunogenetics 1995. 41: 178-228.
19. Maryanski, J. L., Jongeneel, C. V., Bucher, P., Casanova, J. L. and Walker, P. R., Single-cell PCR analysis of TCR repertoires selected by antigen in vivo: a high magnitude CD8 response is comprised of very few clones. Immunity 1996. 4: 47-55.
20. Sant'Angelo, D. B., Waterbury, G., Preston-Hurlburt, P., Yoon, S. T., Medzhitov, R., Hong, S. C. and Janeway, C. A., Jr., The specificity and orientation of a TCR to its peptide-MHC class II ligands. Immunity 1996. 4: 367-376.
21. Stern, L. J., Brown, J. H., Jardetzky, T. S., Gorga, J. C., Urban, R. G., Strominger, J. L. and Wiley, D. C., Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 1994. 368: 215-221.
22. Garboczi, D. N., Ghosh, P., Utz, U., Fan, Q. R., Biddison, W. E. and Wiley, D. C., Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature 1996. 384: 134-141.
23. Garcia, K. C., Degano, M., Stanfield, R. L., Brunmark, A., Jackson, M. R., Peterson, P. A., Teyton, L. and Wilson, I. A., An alphabeta T cell receptor structure at 2.5 A and its orientation in the TCR-MHC complex. Science 1996. 274: 209-219.
24. Loftus, D. J., Castelli, C., Clay, T. M., Squarcina, P., Marincola, F. M., Nishimura, M. I., Parmiani, G., Appella, E. and Rivoltini, L., Identification of epitope mimics recognized by CTL reactive to the melanoma/ melanocyte-derived peptide MART-1(27-35). J. Exp. Med. 1996. 184: 647-657.
25. Hemmer, B., Fleckenstein, B. T., Vergelli, M., Jung, G., McFarland, H., Martin, R. and Wiesmüller, K. H., Identification of high potency microbial and self ligands for a human autoreactive class II-restricted T cell clone. J. Exp. Med. 1997. 185: 1651-1659.
26. Cuende, J. I., Ruiz, J. and Civeira, M. P., High prevalence of HHV-6 DNA in peripheral blood mononuclear cells of healthy individuals detected by nested-PCR. J. Med. Virol. 1994. 43: 115-118.
27. Niederman, J. C., Liu, C. R. and Kaplan, M. H., Clinical and serological features of human herpesvirus-6 infection in three adults. Lancet 1988. 2: 817-818.
28. Kondo, K., Kondo, T. and Okuno, T., Latent human herpesvirus 6 infection of human monocytes/macrophages. J. Gen. Virol. 1991. 72: 1401-1408.
29. Dobrescu, D., Ursea, B., Pope, M., Asch, A. S. and Posnett, D. N., Enhanced HIV-1 replication in V beta 12 T cells due to human cytomegalovirus in monocytes: evidence for a putative herpesvirus superantigen. Cell 1995. 82: 753-763.
30. Conrad, B., Weissmahr, R. N., Boni, J., Arcari, R., Schupbach, J. and Mach, B., A human endogenous retroviral superantigen as candidate autoimmune gene in type I diabetes. Cell 1997. 90: 303-313.
31. Wicker, L. S., Chen, S. L., Nepom, G. T., Elliott, J. F., Freed, D. C., Bansal, A., Zheng, S., Herman, A., Lernmark, A., Zaller, D. M., Peterson, L. B., Rothbard, J. B., Cummings, R. and Whiteley, P. J., Naturally processed T cell epitopes from human glutamic acid decarboxylase identified using mice transgenic for the type 1 diabetes-associated human MHC class II allele, DRB1*0401. J. Clin. Invest. 1996. 98: 2597-2603.
32. Endl, J., Otto, H., Jung, G., Dreisbusch, B., Donie, F., Stahl, P., Elbracht, R., Schmitz, G., Meinl, E., Hummel, M., Ziegler, A. G., Wank, R. and Schendel, D. J., Identification of naturally processed T cell epitopes from glutamic acid decarboxylase presented in the context of HLA-DR alleles by T lymphocytes of recent onset IDDM patients. J. Clin. Invest. 1997. 99: 2405-2415.